Could germline variants in Hedgehog signaling pathway genes impact on melanoma predisposition?
Background: Germline variants in the Hedgehog signaling (SHH) pathway (PTCH1, PTCH2 and SUFU genes) predispose to Nevoid Basal-Cell Carcinoma Syndrome (NBCCS)/Gorlin Syndrome (GS) with high penetrance and variable expressivity. NBCCS/GS is a rare autosomal dominant disease characterized by a wide range of abnormalities and tumor predisposition, mainly multiple basal cell carcinomas (BCCs), medulloblastoma, cardiac and gonadal tumors [1]. It has also been reported that patients with basal cell carcinoma had a significantly higher incidence of melanoma than patients without basal cell carcinoma.
Authors
- Stefania Pellegrini (ORCID: https://orcid.org/0000-0001-5198-5901)
- Monica Quaggio
- Maria Chiara Scaini (ORCID: https://orcid.org/0000-0002-9583-3034)
- Chiara Menin (ORCID: https://orcid.org/0000-0002-8907-772X)
- Antonella Vecchiato
- Milena Gusella (ORCID: https://orcid.org/0000-0002-6257-0282)
- Debora Tonello
Institutions
- University of Padua (IT)
- Istituto Oncologico Veneto (IT)
- Polo d’Innovazione di Genomica (IT)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100392
- Primary Topic
- Hedgehog Signaling Pathway Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00